evaluation the effect of virtual pulmonary rehabilitaion on covid 19 patients
Not Applicable
Recruiting
- Conditions
- COVID 19.
- Registration Number
- IRCT20200930048892N1
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Definite diagnosis of covid 19 with PCR
Hospitalization during the acute phase of the disease
Lung involvement with a typical pattern of covid 19 in chest X ray or chest CT scan
Being clinically stable
Being able to understand and perform the virtual respiratory exercises as given to them in the study
Age > 18 and < 60 years
Exclusion Criteria
COPD, asthma and any other respiratory disease
Neuromuscular disorders that affect lung function
History of ischemic heart disease, congestive heart failure and uncontrolled hypertension
Asymptomatic carriers
Sever comorbid conditions
Disagree to participate in the study
Lack of access to the internet and virtual applications
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The perceived dyspnea severity during daily activities. Timepoint: Before intervention and 8 weeks after study. Method of measurement: Medical Research Council Scale.;The severity of dyspnea. Timepoint: Before intervention and 8 weeks after study. Method of measurement: Modified Borg Scale.;General health-related quality of life. Timepoint: Before intervention and 8 weeks after study. Method of measurement: Short-Form 36 (SF-36).;Psychological state and mood disorder. Timepoint: Before intervention and 8 weeks after study. Method of measurement: The Hospital Anxiety and Depression Scale (HADS).
- Secondary Outcome Measures
Name Time Method